Krystal J. Lin

Nov 13, 2024 | mondaq.com | David Chen |Huiya Wu |Kristopher Brown |Krystal J. Lin

Goodwin is presenting a two-part publication series covering life sciences trends involving license deals, M&A, and financing for Greater China's life sciences sector. See the first post in the series here. While the overall Chinese M&A market fluctuated from 2021 to 2023 due to the pandemic and other factors, the life sciences pharmaceutical and biotech market remained relatively stable. Though the number of deals dipped in 2022, in 2023, it quickly recovered to 2021 levels.

Sep 27, 2024 | mondaq.com | Jacqueline Klosek |Omer Tene |Krystal J. Lin

Colorado has become the first US state to directly regulate neurotechnology by amending its Colorado Privacy Act to protect biological and neural data. This groundbreaking legislation addresses growing concerns about privacy, security, and ethical implications of collecting and analyzing neural information through brain-computer interfaces and other emerging technologies.

Sep 24, 2024 | law360.com | Omer Tene |Jacqueline Klosek |Krystal J. Lin

By Omer Tene, Jacqueline Klosek and Krystal Lin (September 24, 2024, 4:46 PM EDT) -- For centuries, people have been fascinated and intimidated by the specter of divine, human or technological capabilities to read minds. Over the past few years, this vision has materialized in reality, triggering hope for groundbreaking health outcomes alongside concerns about privacy, security fairness and equity.... Law360 is on it, so you are, too.